Close Menu

NEW YORK – Sysmex announced today that it has obtained manufacturing and marketing approval from the Japanese Ministry of Health, Labor, and Welfare for its OncoBEAM RAS Colorectal Kit which tests for mutations in the RAS gene in blood-based circulating tumor DNA (ctDNA) for late-stage CRC patients.

Sysmex believes that physicians can use the assay to help determine whether to use anti-EGFR drugs during treatment.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.